US Broker Ratings

Abbott Laboratories (ABT) Stock Analysis: Navigating a 13.89% Potential Upside in the Healthcare Sector

Abbott Laboratories (NYSE: ABT), a prominent player in the healthcare sector, offers a compelling opportunity for investors seeking exposure to the medical devices industry. With a market capitalization of approximately..

Royalty Pharma plc (RPRX) Investor Outlook: Unlocking a 19.43% Upside with Strategic Biopharma Royalties

Royalty Pharma plc (NASDAQ: RPRX), a prominent player in the biotechnology industry, is strategically positioned at the intersection of healthcare and investment, offering investors a unique opportunity to capitalize on..

Insmed Incorporated (INSM) Stock Analysis: A Biotech Leader with 8.10% Upside Potential

For investors eyeing the biotechnology sector, Insmed Incorporated (NASDAQ: INSM) presents a compelling opportunity. Headquartered in Bridgewater, New Jersey, Insmed specializes in developing and commercializing therapies for serious and rare..

West Pharmaceutical Services (WST) Stock Analysis: A Healthcare Giant with a 17.54% Upside Potential

Investors looking for opportunities in the healthcare sector may find West Pharmaceutical Services, Inc. (NYSE: WST) an intriguing proposition. With a market capitalization of $21.4 billion, the company stands as..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Evaluating a 11.78% Potential Upside

GE HealthCare Technologies Inc. (GEHC), a prominent player in the health information services industry, has captured the attention of investors with a notable potential upside of 11.78%. With a market..

Illumina, Inc. (ILMN) Stock Analysis: Evaluating Growth Potential Amidst a Challenging Revenue Landscape

Illumina, Inc. (NASDAQ: ILMN) remains a pivotal player in the healthcare sector, specifically in diagnostics and research, despite facing some headwinds in its financial metrics. Notably, the company’s market capitalization..

Thermo Fisher Scientific (TMO): Investor Outlook Reveals 6.27% Potential Upside Amid Strong Buy Ratings

Thermo Fisher Scientific Inc. (NYSE: TMO) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $216.18 billion, the..

The Cooper Companies, Inc. (COO) Stock Analysis: Insights into Its 12.91% Potential Upside

The Cooper Companies, Inc. (NYSE: COO) is a prominent player in the healthcare sector, specifically in the medical instruments and supplies industry. With a market capitalization of $14.61 billion, the..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Navigating Growth in Biotechnology with a 14% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player in the biotechnology sector, boasting a robust market capitalization of $108.04 billion. As a leader in developing treatments for cystic..

GSK plc (GSK) Investor Outlook: Exploring Growth Potential Amidst a 3.81% Dividend Yield and Strong ROE

GSK plc (NYSE: GSK), a titan in the healthcare sector, continues to command investor attention with its robust market position in the drug manufacturing industry. Based in London, GSK is..

Hologic, Inc. (HOLX): Analyst Consensus and Growth Potential in the Healthcare Sector

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, continues to evolve as a significant entity in the medical instruments and supplies industry. With a market capitalization of..

ResMed Inc. (RMD) Stock Analysis: Uncovering a Potential 13.99% Upside in Healthcare Innovation

ResMed Inc. (RMD) is a prominent player in the healthcare sector, particularly within the medical instruments and supplies industry. Headquartered in San Diego, California, ResMed is a leader in developing,..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Navigating a $60.75 Billion Biotech Powerhouse

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in the biotechnology sector, is capturing investors’ attention with its substantial market capitalization of $60.75 billion. Based in Cambridge, Massachusetts, the company is..

Sanofi (SNY) Stock Analysis: A 17% Upside Potential with Strong Dividend Yield

Sanofi (NASDAQ: SNY), a titan in the healthcare sector, is headquartered in Paris, France. With a market capitalization of $125.79 billion, Sanofi is a significant player in the industry, particularly..

Insulet Corporation (PODD) Stock Analysis: A 13% Potential Upside with Strong Buy Ratings

Insulet Corporation (NASDAQ: PODD) is making notable strides in the healthcare sector, specifically within the medical devices industry. Known for its innovative insulin delivery systems, Insulet offers products like the..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A Healthcare Titan with Limited Upside Potential

IQVIA Holdings, Inc. (NYSE: IQV), a leader in the healthcare sector, is a noteworthy player in the diagnostics and research industry. With a market capitalization of $37.49 billion, the company..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a Potential 65% Upside in the Biotech Sector

Summit Therapeutics Inc. (NASDAQ: SMMT) is capturing the attention of investors in the biotechnology sector with its promising drug development pipeline and impressive market cap of $14.35 billion. As a..

Quest Diagnostics (DGX) Investor Outlook: Analyzing Potential Upside Amidst Robust Revenue Growth

For investors navigating the healthcare sector, Quest Diagnostics Incorporated (NYSE: DGX) presents an intriguing opportunity, bolstered by its substantial market capitalization of $20.27 billion. With its headquarters in Secaucus, New..

Veeva Systems Inc. (VEEV) Stock Analysis: A Strong Buy with 9.42% Potential Upside

Veeva Systems Inc. (NYSE: VEEV) is a prominent player in the healthcare sector, specifically within the health information services industry. As a leading provider of cloud-based solutions tailored for the..

The Cigna Group (CI) Stock Analysis: Exploring a 21.45% Upside Potential in the Healthcare Sector

The Cigna Group (NYSE: CI) has emerged as a compelling option for investors seeking a robust presence in the healthcare sector. With a market capitalization of $80.55 billion, Cigna operates..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds